Evidence map›Paper›PMID 19241637›Full record

Trial reportJournal of the International Neuropsychological Society : JINS2009

Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease.

Leslie J Gonzalez Rothi, Renee Fuller, Susan A Leon, Diane Kendall, Anna Moore, Samuel S Wu, Bruce Crosson, Kenneth M Heilman, Stephen E Nadeau

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Journal of the International Neuropsychological Society : JINS, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 35 citations in OpenAlex.

  1. A prospective test of the late effects of potentially antineuroplastic drugs in a stroke rehabilitation study.International journal of stroke : official journal of the International Stroke Society · 2014
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Visual discrimination predicts naming and semantic association accuracy in Alzheimer disease.Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2010
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Leslie J Gonzalez RothiBrain Rehabilitation Research Center, Malcom Randall VA Medical Center, Gainesville, Florida 32608-1197, USA. gonzalj@neurology.ufl
Renee Fuller
Susan A Leon
Diane Kendall
Anna Moore
Samuel S Wu
Bruce Crosson
Kenneth M Heilman
Stephen E Nadeau
Malcom Randall VA Medical Center · USUniversity of Florida · USAtlanta VA Medical Center · USCardinal Hill Rehabilitation Hospital · USGeriatric Research Education and Clinical Center · USUniversity of Washington · US

Funding

Treatment of emotion communication deficitsP50DC003888 · NIDCD · UNIVERSITY OF FLORIDA · PI GONZALEZ-ROTHI, LESLIE J · 2000 to 2003
$5.2M
NIDCD NIH HHS P50 DC003888NIDCD NIH HHS P50 DC 03888
6 · The paper itself

Abstract

Six individuals with probable Alzheimer's disease (AD) participated in a phase 1 study employing a repeated measures, parallel baseline design testing the hypothesis that error-free experience during word production practice combined with an acetyl cholinesterase inhibitor would improve confrontation naming ability. While acetyl cholinesterase inhibitors are safe and delay cognition decline associated with AD, improvement over baseline cognition is less evident; clinically significant cognitive deficits persist and progress. Both animal and clinical research strongly implicate acetylcholine in learning, a form of neuroplasticity. In clinical practice, however, people with AD are given cholinergic medications without concomitant systematic/targeted retraining. In this study six participants with probable AD and taking donepezil participated in targeted word production practice using an errorless learning strategy. Results showed that combining behavioral enrichment training and an acetyl cholinesterase inhibitor resulted in significant improvements in verbal confrontation naming of trained items for three of six participants. Differences in baseline dementia severity, living conditions, and medications may have influenced the training response. Detection of substantial treatment effects in 50% of subjects suggests further language treatment studies in AD in combination with an acetyl cholinesterase inhibitor are warranted and provide useful information on inclusion/exclusion criteria for use in subsequent studies.

Indexed as

AdultAgedAged, 80 and overAlzheimer DiseaseBehavior TherapyCholinesterase InhibitorsDonepezilFemaleHumansIndansMaleMiddle AgedNeuropsychological TestsPiperidinesTreatment OutcomeCholinesterase InhibitorsDonepezilIndansPiperidines

Identifiers

PMID19241637
PMCPMC3010871
OpenAlexW2065443017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.